FDA Warning Letter — RIVERSIDE LIQUOR

Case 696678 — FEI 3033027661

The FDA took a Warning Letter action against RIVERSIDE LIQUOR on Nov 14, 2024 (Lyndhurst, NJ). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
RIVERSIDE LIQUOR
Date
Nov 14, 2024
Fiscal Year
2025
Product Type
Tobacco
Center
CTP
Location
Lyndhurst, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.